Lung cancer fingerprint hunt: 4,000 patients join search for clues

NCT ID NCT00897117

Recruiting now Knowledge-focused Sponsor: Vanderbilt-Ingram Cancer Center Source: ClinicalTrials.gov ↗

First seen Oct 01, 2025 · Last updated May 10, 2026 · Updated 26 times

Summary

This research study collects and analyzes lung tumor samples from 4,000 people with early-stage non-small cell lung cancer who are having surgery. The goal is to find unique patterns in RNA and proteins (molecular fingerprints) that may help predict cancer recurrence and survival. No new treatment is given; the study focuses on understanding the disease better.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Dan Rudy Cancer Center at Saint Thomas Hospital
COMPLETED

Nashville, Tennessee, 37205, United States
Vanderbilt-Ingram Cancer Center
RECRUITING

Nashville, Tennessee, 37232-6838, United States

Contact Phone: •••-•••-••••
Veterans Affairs Medical Center - Nashville
SUSPENDED

Nashville, Tennessee, 37212, United States

Conditions

Explore the condition pages connected to this study.

LUNG CANCER